Predicting the efficacy of first-line immunotherapy by combining cancer cachexia and tumor burden in advanced non-small cell lung cancer.

Taichi MiyawakiTateaki Naito Kosei DoshitaHiroaki KodamaMikiko MoriNaoya NishiokaYuko IidaEriko MiyawakiNobuaki MamesayaHaruki KobayashiShota OmoriRyo KoKazushige WakudaAkira OnoHirotsugu KenmotsuHaruyasu MurakamiKeita MoriHideyuki HaradaMasahiro EndoKazuhisa TakahashiToshiaki Takahashi

Published in: Thoracic cancer (2022)

We proposed the immune predictive model, including tumor burden and cancer cachexia, which may predict the efficacy and survival outcome of first-line immunotherapy in advanced NSCLC.

Keyphrases

advanced non small cell lung cancer
papillary thyroid
epidermal growth factor receptor
squamous cell
small cell lung cancer
risk factors
lymph node metastasis
squamous cell carcinoma
childhood cancer
tyrosine kinase